| Financial Year |
March 31 2023 |
| Monetary Funds |
142,489,463.03 |
| Held-for-trading Financial Assets |
48,139,219.81 |
| Notes Receivable |
184,523,551.62 |
| Accounts Receivable |
741,880,366.57 |
| Advances to Suppliers |
71,561,808.35 |
| Other Receivables |
35,041,000.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
431,405,149.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,979,788.15 |
| Total Current Assets |
1,704,560,866.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
64,570,834.50 |
| Long-term Equity Investment |
231,644,897.89 |
| Investment Properties |
3,621,298.96 |
| Fixed Assetes |
205,923,115.39 |
| Under-construction Projects |
10,463,177.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,294,570.41 |
| R&D expenses |
-- |
| Goodwill |
49,855,207.30 |
| Long-Term Deferred and Prepaid Expenses |
16,644,383.46 |
| Deferred Income Tax Assets |
17,225,437.79 |
| Other Non-Current Assets |
7,788,148.00 |
| Sub-Total of Non-Current Assets |
688,606,571.82 |
| Total Assets |
2,393,167,438.73 |
| Short-Term Loans |
302,259,722.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,265,830.44 |
| Accounts Payable |
370,939,573.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,266,483.94 |
| Taxes Payable |
35,132,074.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,801,111.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,116,569.44 |
| Other Current Liabilities |
211,233,015.82 |
| Sub-Total of Current Liabilities |
1,116,621,402.86 |
| Long-term Loans |
121,980,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,580,512.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,755,470.09 |
| Total Liabilities |
1,256,376,872.95 |
| Paid-In Capital(Or Share Stock) |
312,000,000.00 |
| Capital Surplus |
211,699,301.96 |
| Surplus Reserve |
104,196,933.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
460,482,273.87 |
| Minority Stockholder's Interest |
38,465,974.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,098,324,591.63 |
| Owner's Equity（Stockholder's Equity） |
1,136,790,565.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,393,167,438.73 |
